BIOMEDICAL SCIENCE • UNIVERSITY PRESENTATION
Application & Utility of Blood Glucose Monitoring
From a finger-stick number to real-time clinical decision-making
BGM → CGM → ACTION
Capillary blood glucose • continuous glucose monitoring • clinical translation
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
1
BIOMEDICAL SCIENCE • UNIVERSITY PRESENTATION
Application & Utility of Blood Glucose Monitoring
From a finger-stick number to real-time clinical decision-making
BGM → CGM → ACTION
Capillary blood glucose • continuous glucose monitoring • clinical translation
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
1
01 • WHY MONITOR?
Glucose is a dynamic biomarker
A single value is useful; a pattern is actionable.
POST-MEAL SPIKE
Meals can expose hidden excursions.
HYPOGLYCAEMIA
Low readings can trigger rapid action.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
2
02 • TECHNOLOGY
Two complementary monitoring approaches
Capillary BGM gives a point-in-time measurement; CGM adds direction and context.
CAPILLARY BGM
Finger-stick → blood sample → meter
Fast, practical, and essential as a backup when CGM is unavailable or uncertain.
CONTINUOUS GLUCOSE MONITORING
Sensor → interstitial glucose → trend data
Shows trajectories, alerts and metrics such as Time in Range (TIR).
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
3
03 • CLINICAL UTILITY
Where monitoring changes decisions
The value is not the number alone — it is what the number enables.
INSULIN TITRATION
Adjust basal / bolus therapy using glucose patterns.
HYPOGLYCAEMIA
Detect, prevent and treat low glucose.
NUTRITION & ACTIVITY
See responses to meals and exercise.
SAFETY
Support decisions around illness and critical tasks.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
4
04 • CLINICAL METRICS
CGM turns glucose into a time series
Three metrics make the data easier to interpret.
TIME IN RANGE
70–180 mg/dL (3.9–10.0 mmol/L)
How long glucose stays in the target zone.
TIME BELOW RANGE
<70 mg/dL (<3.9 mmol/L)
Highlights hypoglycaemia burden.
TIME ABOVE RANGE
>180 mg/dL (>10.0 mmol/L)
Shows hyperglycaemia burden.
A 10–14 day CGM assessment with adequate wear can support clinical assessment of glycaemic patterns.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
5
05 • BEYOND ROUTINE DIABETES CARE
Applications across biomedicine
Monitoring is increasingly connected to physiology, treatment and digital health.
HOSPITAL CARE
Point-of-care glucose supports insulin protocols and acute care.
PREGNANCY
CGM can support glycaemic goals in diabetes during pregnancy.
SPORT & EXERCISE
Monitoring helps identify exercise-related glucose changes.
DIGITAL HEALTH
Apps + CGM data can enable remote review and coaching.
RESEARCH
Dense glucose profiles reveal variability that HbA1c alone can miss.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
6
06 • LIMITATIONS
More data ≠ perfect data
Good biomedical practice means knowing when the measurement may mislead.
INTERSTITIAL LAG
CGM measures interstitial glucose; values can lag during rapid change.
ACCURACY / INTERFERENCE
Meters and sensors can be affected by device factors or interfering substances.
SKIN & USABILITY
Adhesion, irritation, alarms and device burden affect sustained use.
CLINICAL CONFIRMATION
If the reading conflicts with symptoms or context, confirm appropriately.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
7
07 • TAKE-HOME MESSAGE
Monitor → interpret → act
Blood glucose monitoring is a measurement system — not just a test.
MEASURE
BGM / CGM
INTERPRET
Pattern + trend
ACT
Therapy / lifestyle
REVIEW
Outcome + safety
Best practice combines accurate measurement, patient-centred technology, clinical context and informed action.
2026 framing: BGM remains essential; CGM increasingly adds continuous context and actionable trends.
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
8
REFERENCES
Selected evidence & guidance
Use these sources in your speaker notes / reference list.
American Diabetes Association. Standards of Care in Diabetes—2026. Section 7: Diabetes Technology.
diabetesjournals.org/care • 2026
American Diabetes Association. Standards of Care in Diabetes—2025. Section 6: Glycemic Goals and Hypoglycemia.
diabetesjournals.org/care • 2025
NICE NG17. Type 1 diabetes in adults: diagnosis and management — recommendations on CGM and self-monitoring.
nice.org.uk/guidance/NG17
BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING
9